GlaxoSmithKline: Attention Is Now Shifting To Vaccine Manufacturing Aug. 21, 2020 9:39 AM ET GSK plc (GSK) Stock AZN , DVAX , IBIO , MRNA , PFE , SNY , VIR , GSK 27 Comments 19 Likes Chetan Woodun ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

Earlier this year, GSK said it would invest £200 million (around $260 million) in upgrades to its manufacturing network in the UK, including a revamp of a plant in Melrose, Scotland, used to make ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...

Two consequences of GlaxoSmithKline's recent decision to divest some of its less robust consumer products are the sale of a manufacturing plant in Memphis and another in Aiken, SC. The Memphis ...

The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines drug substance facility and an R&D pilot plant.

GSK says EU pharma legislation overhaul could trigger investment shift ... goal of improving access to medicines for all Europeans and that the region was critical to GSK's R&D and manufacturing.

GlaxoSmithKline, an early adopter of continuous processing as a way to cut drug manufacturing costs and manufacturing waste, and thus its impact on the environment, is committing $25 million to ...

Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the ...

MARIETTA, Pa. (WHTM) — A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster County manufacturing facility. During a press ...